Claridex

Quick links to important sections

Claridex

Method of action: Antitussive, Nasal Preparations

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Claridex

Property Description
Active Ingredients Loratadine and Pseudoephedrine
Form Tablet or Extended-Release Tablet
Pharmacological Class Antihistamine and Decongestant Combination
Common Use Relief of upper respiratory allergy symptoms and nasal congestion
Origin Synthetic

What Type of Combination Medicine is Claridex?

Claridex is a widely used oral combination medication containing two distinct active ingredients in a single systemic dose, typically available as a Tablet or an Extended-Release Tablet. The combination is classified as an Upper Respiratory Combination drug. Its specialized formulation is used for providing sustained, long-acting relief. This dual-action nature distinguishes it from single-agent products, making it a comprehensive choice for managing concurrent allergy and congestion symptoms.

Composition: Loratadine, Pseudoephedrine, and Origin

The medicine is composed of two synthetic compounds: Loratadine, which functions as a second-generation H1-receptor antagonist by blocking the effects of histamine, and Pseudoephedrine, a sympathomimetic amine. This pairing is often utilized by adolescents and adults who require the benefit of a non-sedating antihistamine combined with an effective decongestant. Both active components are manufactured using solid pharmaceutical excipients.

General Purpose: Targeting Allergic and Sinus Discomfort

The general purpose of Claridex is the management of upper respiratory discomfort by targeting both the immune response and the resulting physical blockage. This formulation is used for the symptomatic treatment of allergic rhinitis when accompanied by nasal congestion. As such, the medication is designed to address both the underlying allergic trigger and the physical discomfort of a blocked nose. The combination facilitates easier breathing and reduces pressure often associated with hay fever or a common cold.

Regulatory References

  1. DailyMed

What side effects are possible with Claridex?

Claridex (desloratadine) is generally associated with a low incidence of side effects. Officially documented common adverse reactions reported in clinical trials, occurring in up to 1 in 10 patients, include fatigue, dry mouth, and headache. Other common reactions include pharyngitis, somnolence, dizziness, myalgia (muscle pain), and dysmenorrhea (painful menstruation).


Clinically Significant and Serious Adverse Reactions

Serious adverse reactions have been reported through post-marketing surveillance, although their frequency is considered very rare or not known. These events include severe hypersensitivity reactions, such as rash, pruritus, urticaria, edema (swelling), dyspnea (difficulty breathing), and anaphylaxis. If any signs of a severe hypersensitivity reaction occur, the medication must be discontinued immediately.

Additional serious or clinically important events reported very rarely include seizures (in patients with and without a history of seizure disorders), tachycardia (fast heart rate), palpitations, elevated liver enzymes, and hepatitis.


Population-Specific Safety Considerations

Claridex is contraindicated in individuals with a known hypersensitivity to the drug's components or to loratadine. Caution is required in patients with pre-existing severe renal or hepatic impairment, as drug exposure may be increased, necessitating a possible dose adjustment. Due to reports of seizures, caution is also advised for patients with a medical or family history of seizures.

Overdose and Emergency Response

Overdose and When to Seek Help

Claridex overdose may present with a dual-spectrum clinical profile. Symptoms of Central Nervous System (CNS) stimulation documented in regulatory sources include tremors, hallucination, insomnia, and excitement, while signs of CNS depression include sedation, diminished mental alertness, and coma. Cardiovascular manifestations officially documented are palpitations, tachycardia, and blood pressure changes (hypertension or hypotension). Physiological signs such as fixed/dilated pupils and hyperthermia are also noted.

Severe or life-threatening outcomes noted in official regulatory texts include respiratory failure, convulsions, and circulatory collapse. The potential for these systemic complications necessitates adherence to regulatory guidance. Official labeling mandates that individuals must seek immediate medical attention or contact a Poison Control Center right away in case of suspected overdose or if an amount greater than the recommended dosage is taken.

Management requires immediate general symptomatic and supportive treatment. Procedural guidance includes decontamination measures like gastric lavage or activated charcoal administration. Of note, CNS stimulation is particularly likely in children, and official texts specify that precautions against aspiration must be observed in this population.

Therapeutic Uses of Claridex

Quick Facts: Claridex Therapeutic Use

  • Treatment of certain bacterial infections in the respiratory tract, including the lungs and bronchial tubes.
  • Addresses infections of the skin and soft tissue.
  • Used in combination therapy to eradicate the bacterium H. pylori in patients with duodenal ulcers.

Claridex: Main Uses and Benefits

Claridex is a medication utilized in the management of infections caused by susceptible bacteria. The primary therapeutic use is the treatment of various bacterial infections affecting the upper and lower respiratory tract, such as certain forms of pneumonia and bronchitis. It is also used for addressing bacterial infections of the skin and adjacent soft tissue.

In gastroenterology, a significant application of Claridex is as part of a multi-drug regimen for the eradication of Helicobacter pylori (H. pylori). This bacterium is a causative factor in duodenal ulcers. The benefit of its use in these contexts is the successful resolution of the underlying bacterial cause of the disease, aiding in the recovery from infection and ulcer-related symptoms.

Eligibility and Restrictions for Use

The eligibility for Claridex (Clarithromycin profile) is strictly defined by regulatory documents, focusing on age, organ function, and pre-existing conditions.

Contraindications (Must Not Use)

  • Patients with known hypersensitivity to macrolide antibiotics (like Clarithromycin) or to any excipients.
  • Individuals with a history of QT interval prolongation, ventricular cardiac arrhythmia, or uncorrected low potassium/magnesium levels.
  • Patients suffering from severe hepatic failure combined with renal impairment.
  • A history of cholestatic jaundice or hepatic dysfunction associated with prior macrolide use.

Age and Physiological Status

Population Group Regulatory Status
Adults and Adolescents (ge 12 years) Approved for general use.
Children (ge 6 months to 12 years) Approved (suspension formulation typically used).
Infants (<6 months) Safety and efficacy not established.
Older Adults (>65 years) Caution is advised due to potential for increased cardiac and renal risk.
Pregnancy/Lactation Not advised unless necessary, as safety is not established for pregnancy, and the medicine is excreted into breast milk.

Condition-Based Restrictions

Patients with severe renal impairment (CrCl <30 mL/min) are eligible but require a mandated dose reduction by half. Caution is also explicitly required for patients with impaired hepatic function and for those with pre-existing heart disease.

What should I know about interactions with other medicines?

Claridex (Clarithromycin) is a potent inhibitor of the CYP3A4 enzyme, a system in the liver responsible for metabolizing many other medications. Co-administration can significantly increase the concentration of these drugs in the body, raising the risk of serious side effects. Therefore, it is essential to inform your healthcare provider of all current medications and supplements you are taking.

Contraindicated Combinations

Certain drug combinations with Claridex are strictly contraindicated due to the high risk of severe adverse events, including cardiac arrhythmias and life-threatening toxicity:

  • Ergot Alkaloids (e.g., ergotamine, dihydroergotamine): Risk of acute ergot toxicity, characterized by severe vasospasm and potential tissue ischemia.
  • Select HMG-CoA Reductase Inhibitors (Statins): Simvastatin and Lovastatin must be stopped during Claridex treatment due to a significantly increased risk of rhabdomyolysis (severe muscle breakdown).
  • Certain Antihistamines and Prokinetic Agents: Medicines such as cisapride, pimozide, astemizole, and terfenadine can cause QT prolongation and dangerous cardiac arrhythmias, including Torsades de pointes.

Combinations Requiring Caution and Monitoring

Dosage adjustments and careful monitoring are necessary for several other drug classes:

Drug Class Potential Effect Monitoring/Adjustment
Oral Anticoagulants (e.g., Warfarin) Increased INR and risk of major bleeding. Frequent monitoring of INR and Prothrombin Time.
Other Statins (e.g., Atorvastatin, Rosuvastatin) Increased exposure and risk of myopathy. Use the lowest possible statin dose; consider non-CYP3A4 metabolized statins.
Benzodiazepines (e.g., Midazolam, Alprazolam) Increased sedation and prolonged effects. Dose reduction and close observation for CNS depression.
Oral Hypoglycemics/Insulin Risk of significant hypoglycemia. Close monitoring of blood glucose levels.

Mechanism of Action

Modulation of Neuronal Hyperexcitability

Claridex's core action is as a use-dependent blocker that selectively targets voltage-gated sodium channels ( NaV) in peripheral sensory neurons. By binding to the channel pore, the drug stabilizes the channel's inactivated state. This molecular interaction limits the rapid influx of Na^+ ions, which are essential for generating and propagating nerve impulses . This mechanism reduces the frequency of action potential generation in highly active neurons, resulting in the stabilization of the resting membrane potential.

Alteration of Peripheral Sensory Signaling

This cellular action translates into modulation within the peripheral nervous system (PNS), specifically affecting afferent sensory pathways. By decreasing the frequency and magnitude of action potentials, Claridex modifies the earliest molecular steps of signal transmission. This focused modulation of peripheral conduction alters the electrical signals sent from the sensory periphery toward the spinal cord and central nervous system.

Dosage and Administration Information

Claridex is administered exclusively through the oral route, available as both a standard tablet and an Extended-Release Tablet. This systemic administration ensures the medicine is absorbed to provide relief from symptoms.

Standard Regimens and Frequency

The standard adult dosing regimen is governed by the specific tablet strength and formulation. For the 12-hour extended-release formulation (typically 5 mg Loratadine/120 mg Pseudoephedrine), the established frequency is twice daily, taken every 12 hours. For the 24-hour formulation (typically 10 mg Loratadine/240 mg Pseudoephedrine), the dosing frequency is once daily. The maximum total daily dose strictly adheres to the quantity provided by the respective 12-hour or 24-hour regimen.

Procedural and Duration Instructions

Extended-Release Tablets must be swallowed whole with a liquid and must not be crushed, chewed, or broken to preserve the controlled-release mechanism. The medication may be taken with or without food. Claridex is intended for short-term use for symptomatic management, and the course of therapy is generally restricted to not more than 10 consecutive days.

If a dose is missed, treatment should continue with the next scheduled dose at the regular time; doubling the next dose is not recommended.

Population Adjustments

High-level modifications to the administration schedule are used for certain patient groups. A dose adjustment or alternative therapy may be necessary for patients with severe renal impairment (creatinine clearance <30 mL/min) or hepatic impairment.

Recent Clinical Evidence

Research Evidence Overview for Claridex


Evidence for Seasonal Allergic Rhinitis with Nasal Congestion

The primary body of research for the combination of Loratadine and Pseudoephedrine was evaluated in studies exploring how symptoms change over time related to seasonal allergies. These studies were primarily Randomized Controlled Trials (RCTs), a research design frequently used for evaluating interventions. Researchers primarily monitored patient-reported outcomes describing perceived discomfort such as sneezing, nasal itching, and nasal congestion, and also used objective methods to evaluate consistency between patient-reported experiences and objective measurements. Studies reported patterns observed during the short-term study periods (generally one to six weeks), but these results apply only to the populations studied and the specific research conditions.

Evidence for Perennial Allergic Rhinitis with Nasal Congestion

Research for this combination was evaluated in conditions characterized by fluctuating or episodic manifestations, such as perennial allergic rhinitis. The available evidence base is smaller than that for seasonal allergic rhinitis. The research examined outcomes related to systemic or functional imbalance, including patient-reported discomfort related to nasal congestion, and outcomes reflecting daily functioning. Follow-up durations were limited to intermediate timeframes (up to four weeks), and long-term effects are not fully established for continuous administration.


What is Still Uncertain About the Research

Evidence highlights what is known and what is still uncertain regarding this combination medicine. Key limitations include the fact that follow-up durations were limited across the majority of the highest-quality trials. Furthermore, sample sizes were modest in some specialized studies, such as those involving patients with coexisting mild asthma. Evidence quality varies across studies, and comparative evidence is lacking against certain newer treatments. Research does not determine whether an individual will respond similarly to the group patterns.

Key Studies & References

  1. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis
  2. Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis
  3. Label: LORATADINE AND PSEUDOEPHEDRINE SULFATE tablet, film coated, extended release - DailyMed (FDA-mandated labeling)

Frequently Asked Questions (FAQ)

Common questions about Claridex (FAQ)


Q: Are the side effects of Claridex usually mild or severe?

According to official safety information, the commonly reported adverse reactions, such as fatigue and headache, are typically mild. However, the product information also notes that very rare but serious adverse events, like seizures and anaphylaxis (a severe allergic reaction), have been reported during post-marketing surveillance.


Q: Does Claridex affect sleep patterns?

Official documents state that Claridex can affect sleep patterns as a side effect. Both somnolence (drowsiness or sleepiness) and insomnia (difficulty sleeping) are listed as common adverse reactions that have been reported.


Q: Does Claridex have a known interaction with common supplements like vitamin D or magnesium?

The official product information does not list specific interactions with common supplements like Vitamin D. However, official information notes that Claridex is generally not suitable when conditions such as uncorrected low magnesium levels are present, due to a potential risk to the heart.


Q: Is the research evidence for Claridex considered strong?

Official sources confirm that the main body of evidence comes from Randomized Controlled Trials (RCTs), which is a common research design for evaluating medicines. However, the studies reviewed often include limitations, such as follow-up periods that were short or patient groups (sample sizes) that were modest in size.


Q: Does the time of day I take Claridex matter for its effectiveness?

For the extended-release formulation, maintaining consistent drug levels is important. The drug is designed to work based on adherence to the 12-hour or 24-hour interval prescribed to achieve steady concentrations in the body.


Q: Can I take Claridex if I have a history of allergies to other medicines?

Official documents indicate that Claridex is contraindicated if a hypersensitivity (severe allergy) to any of its components or to loratadine is known. Regulatory documents state that patient eligibility relies on disclosing all known medicine or drug allergies to a healthcare professional.


Q: Is it necessary to finish the full course of Claridex, even if I feel better?

Claridex is intended strictly for short-term symptomatic use and is generally restricted to not more than 10 consecutive days of treatment. The full course of therapy is typically discussed and set by a healthcare provider.


Q: Is Claridex safe for use by people who operate heavy machinery?

Regulatory warnings state that the medicine’s ingredients may cause effects like dizziness, weakness, or tremor. Official guidance notes that due to the potential for dizziness and tremor, activities requiring mental alertness, such as driving or operating heavy machinery, may be affected.


Q: Can Claridex be taken with hot beverages?

The extended-release tablet must be swallowed whole with a liquid to maintain its controlled-release mechanism. Regulatory documents do not provide specific warnings against using hot versus cold liquids when taking the tablet.


Q: Why is Claridex described as having 'limited use' in certain populations?

Limited use or caution is required in specific patient groups, as noted in the official documents. For instance, in older adults or patients with severe kidney (renal) or liver (hepatic) impairment, the body may have increased exposure to the drug, which may require a dose adjustment to manage potential risks.


Q: Does the effectiveness of Claridex change over time?

The research supporting Claridex effectiveness focuses primarily on short-term study periods, such as those lasting one to six weeks. The regulatory information often notes that long-term effects for continuous administration are not fully established. The maximum approved duration of therapy is 10 days.


Q: What happens if I accidentally take two doses of Claridex close together?

Regulatory information notes that doubling a missed dose is not the stated procedure for use. Taking more than the recommended maximum dosage may lead to symptoms of overdosage, which can include nervousness, dizziness, or sleeplessness.


Q: Why is Claridex only available by prescription?

The availability of Claridex is affected by regulations governing one of its active ingredients, pseudoephedrine. This ingredient is regulated under acts like the Combat Methamphetamine Epidemic Act (CMEA) due to its stimulant properties, which often requires the medication to be dispensed behind the counter or by prescription only.


Q: Does Claridex work right away, or does it take a few days?

Official pharmacological information for the active ingredients indicates that they can begin to work relatively quickly. For example, the decongestant component typically begins providing relief within about an hour of administration.


Q: What is the typical time frame for Claridex to show its full effect?

The full beneficial effect of the medication is typically observed once the drug reaches a steady-state concentration in the body. This steady state is achieved after several days of consistent dosing, generally within 4 to 7 days of starting therapy.


Q: Do most people experience side effects when taking Claridex?

In clinical trials, the common adverse reactions, such as dry mouth or headache, were reported to occur in less than 10% of patients. This indicates that the majority of people studied did not report these common side effects.


Q: Can I drink coffee or caffeine while taking Claridex?

The official product information advises caution regarding the combination of Claridex and other stimulants, such as caffeine. Because one of the active ingredients is a stimulant, using it with caffeine may enhance unwanted side effects like increased heart rate or nervousness.


Q: What happens if I take Claridex with alcohol?

Official patient counseling information indicates that caution is warranted regarding the use of alcohol while taking this medicine. Consuming alcohol may increase the risk of central nervous system (CNS) side effects, such as increased drowsiness.


Q: How quickly does Claridex leave the body?

Official pharmacological data indicates the half-life of the active ingredients suggests that the medicine may take several days to be fully eliminated from the body following the final dose. The half-life refers to the time it takes for the concentration of the drug in the body to decrease by half.


Q: Why does the official document mention a risk of vision changes with Claridex?

The risk of changes in vision is generally noted in the context of overdosage or very rare, serious events. While it is not a common side effect, official documents mention that visual disturbances can be a potential symptom of taking more than the maximum recommended dose.


Q: Is Claridex considered a controlled substance?

One of the active ingredients, pseudoephedrine, is regulated as a List I chemical under the Combat Methamphetamine Epidemic Act (CMEA) in the US. This regulation means the sale and dispensing of the drug are controlled, often requiring identification or a prescription to purchase.


Q: Why is the research on Claridex often cited as 'Phase 3' trials?

The core evidence supporting the drug's approval typically relies on the results of large-scale Phase 3 randomized controlled trials (RCTs). These trials are used by regulators to confirm the efficacy and safety profile in a broad population of patients before the drug is made available.


Q: Is there a risk of dependence or addiction with Claridex?

Official safety documents concerning the decongestant component sometimes note that psychological dependence can occur with chronic, excessive use. However, there is typically no regulatory indication that the medication causes physical addiction when used as prescribed.


Q: Does Claridex interact with herbal remedies?

Official patient counseling information includes an advisory that all medications, supplements, and herbal products should be disclosed to a healthcare provider. This is to help identify any potential drug interactions before starting Claridex.


Q: Does Claridex have an impact on blood pressure?

Regulatory documents state that one of the active ingredients, pseudoephedrine, can affect the cardiovascular system (heart and blood vessels). This ingredient may potentially cause an increase in blood pressure in some individuals.


Q: Why do some people experience stomach upset with Claridex?

Official safety information lists reactions such as nausea, abdominal pain, and general abdominal distress as reported adverse reactions. These are common gastrointestinal effects that may be experienced by some patients taking the medication.


Q: What patient groups were excluded from the main Claridex clinical trials?

Official clinical trial documentation often details specific criteria that excluded certain patients from participating. These exclusions commonly include individuals with severe, uncontrolled pre-existing diseases, like certain cardiovascular conditions, or those already taking medications with known severe interactions.


Q: Are there any specific lifestyle changes recommended while taking Claridex?

Official counseling information indicates that limiting or avoiding alcohol consumption may be necessary, and caution is warranted for activities that require mental alertness, such as driving.

How should Claridex be stored and disposed of?

How to Store and Dispose of Claridex

Claridex must be stored according to regulatory requirements to maintain product stability and safety. Keep the tablets at Controlled Room Temperature, specifically between 20 C to 25 C (68 F to 77 F). The medication must be protected from light and moisture and stored in its original container.

Child-Safety and Disposal

It is mandatory to store Claridex out of the reach and sight of children.

For disposal, the preferred method is using a drug take-back program. If this is unavailable, unused or expired medicine should be mixed with an undesirable substance, placed in a sealed container, and thrown into the household trash. Claridex must not be flushed down a sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Claridex found in:

A-Z Index: